Tumescent anesthesia reduces pain associated with balloon angioplasty of hemodialysis fistulas  by Haines, Wen-Yu V. et al.
VASCULAR AND ENDOVASCULAR TECHNIQUES
Peter F. Lawrence, MD, Section Editor
From the Midwestern Vascular Surgical Society
Tumescent anesthesia reduces pain associated with
balloon angioplasty of hemodialysis fistulas
Wen-Yu V. Haines, MD,a Ryan Deets, BS,b Ning Lu, BS,b and John H. Matsuura, MD,a,c Des Moines and
Iowa City, Iowa
We describe the use of tumescent local anesthesia during endovascular treatment of arteriovenous fistula stenosis. Using
ultrasound guidance, 11 patients were hand-injected with tumescent lidocaine anesthesia around the fistula stenosis prior
to endovascular therapy. All patients rated the pain experienced during angioplasty on a numeric scale (0-10). The mean
balloon inflation pressure was 12  3.01 atm. During angioplasty, eight patients reported pain between 0 and 2; three
patients reported 4, 5, and 7 out of 10 on the pain scale. In this small series, tumescent anesthesia provided adequate pain
control to perform angioplasty of arteriovenous fistulas. ( J Vasc Surg 2012;56:1453-6.)
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RIn the United States there are over 354,000 patients
with renal failure on hemodialysis.1 Endovascular therapy
of failing arteriovenous fistulas (AVFs) has replaced open
surgical revision to prolong the lifespan of the access.2
Balloon angioplasty often requires high inflation pressures
resulting in considerable pain. In the hospital setting, intra-
venous moderate conscious sedation has helped control
most of the procedural pain. The degree of conscious
sedation is often limited by patients’ comorbidities.3 Dilute
local anesthesia or “tumescent anesthesia” offers the ability
to treat larger areas with reduced toxicity.4 We report our
early experience with tumescent local anesthesia during
office-based angioplasty of failing hemodialysis access fistu-
las and grafts.
METHODS
Institutional Review Board approval was received from
Iowa Health - Des Moines to report a retrospective review
of these 11 cases. Between November 15, 2009 and Sep-
tember 30, 2010, all patients included in this report expe-
rienced severe pain with previous AVF angioplasty proce-
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e performed tumescent-assisted angioplasty without re-
uiring patients to be nil per os (NPO). All patients had
ltrasound evaluation (Zonare, Mountain View, Calif) and
dentification of the AVF stenosis. We mixed 5 mL 1%
idocaine HCl (Hospira Inc, Lake Forest, Ill) with 2 mL
.5% sodium bicarbonate (Hospira Inc) and diluted this
nto 23 mL 0.9% saline. Utilizing transverse ultrasound
maging (Fig 1, A-C), the areas of AVF stenosis were
and-injected with the tumescent mixture (Fig 2,A and B).
he volume of tumescent depended on the number of
esions and the length of vein stenosis identified on ultra-
ound. We did not quantify the size of the tumescent
halo” around the treatment site. Successful infiltration was
efined as the presence of fluid around the stenosis. None
f 11 patients had oral or intravenous analgesic or anxi-
lytic agents. Patients then underwent balloon angio-
lasty under fluoroscopic guidance (ARCADIS Avantic;
iemens Medical Solutions USA, Inc, Malvern, Pa). Four
erianastomotic and eight outflow vein stenoses were
reated. The smaller balloon diameters of the perianas-
omotic lesions were sized to match the inflow artery
iameters. The balloon diameters for the outflow venous
tenoses were based on fluoroscopic measurement. The
ain level was recorded using a numeric 0 to 10 scale.
uccess of the intervention was defined as 20% reste-
osis on completion contrast injection and use of the
VF for hemodialysis within 24 hours of the angioplasty
rocedure. Any adverse events, including bleeding,
ransfer to the hospital, and mortality, were recorded.
ESULTS
The median age was 68 years (range, 31-89 years); six
atients were male (54%). The Table summarizes the
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dures among these 11 patients. This includes balloon
size, inflation pressures (atm), volume of tumescent
(mL), and individual numeric pain scale scores. There
Fig 1. Transverse ultrasound image of the arterioveno
identification of AVF stenosis (small arrow) (B). Injec
stenosis (C).
Fig 2. Sterile prep at the site of vein stenosis at the cepha
lidocaine (B).were no deaths. No infections were seen in follow-up. mone of the patients required hospitalization for cardio-
ascular instability, bleeding, or local anesthetic adverse
eactions. After the procedure, all patients had successful
ccess of the AVF for hemodialysis within 24 hours. The
tulas (AVF) proximal to the stenosis (A). Ultrasound
of tumescent lidocaine (large arrow) around the AVF
h on this patient (A) followed by injection of tumescentus fis
tionlic arcean volume of tumescent was 14.5 mL. The mean
t
t
c
t
o
c
c
t
t
a
t
e
m
m
u
A
A
i
a
r
e
y
m
b
t
e
c
w
e
c
m
e
t
d
R
using a
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 5 Haines et al 1455balloon pressure was 12 atm (range, 8-18 atm). The
mean pain scale rating was 2 (range, 0-7).
DISCUSSION
Tumescent anesthesia is not new. In the 1930s, the terms
“massive infiltration” and “hypodermoclysis” described a
method similar to that used by plastic surgeons performing
liposuction today.5 Vascular surgeons adopted this technique
for office-based varicose vein stripping6,7 and laser ablation of
the saphenous vein.8 Major advantages of tumescent local
anesthesia include the ability to treat larger areas with fewer
injections and a reduced risk of lidocaine toxicity.
We sought an alternative to moderate conscious
sedation to provide adequate pain control for endovas-
cular therapy. It seemed reasonable that arm vein fistulas
would respond similarly to a block of the pain receptors
during balloon angioplasty. During the study period, our
Access Center performed 131 angioplasties. Patients in
this report were selected for tumescent-assisted angio-
plasty due to severe pain experienced during similar
previous procedures. Therefore, only 8.4% of patients
required additional therapy for pain control. The major-
ity of patients in our series experienced little pain during
the tumescent-assisted procedure. The patient with the
highest pain score had no pain on angioplasty of a
cephalic vein stenosis, but moderate to severe pain with
angioplasty of an innominate vein stenosis. Although we
attempted infiltration in the mediastinum, the deep lo-
cation of the central veins and limitations of ultrasound
visualization made tumescent local anesthesia an ineffec-
tive technique in the chest.
The time required for tumescent injection prior to the
procedure was under 5 minutes. Since there were no de-
fined fascial compartments in areas of the treated AVFs and
thus no tumescent “halo,” we relied more on the presence
of the tumescent fluid around the site of vein stenosis as
successful infiltration.
The greatest risk of moderate sedation is inadequate
oxygenation and ventilation, which leads to the higher
Table. Summary of the tumescent angioplasty procedures
Patient Age (years) Sex (M/F)
No. of prior
treatments
Type of
access
CW 84 F 3 AVG
JA 31 F 0 AVF
DH 68 F 2 AVF
DM 54 M 2 AVF
TO 59 M 0 AVF
HS 69 M 0 AVF
RC 89 M 4 AVF
HH 86 F 1 AVF
GV 67 F 2 AVF
AG 42 M 0 AVG
EC 77 M 0 AVF
AVF, Arteriovenous fistulas; AVG, arteriovenous grafts.
aCentral stenosis involving the left innominate vein. Visualization of the veinmortality rate.3 Even under well-monitored situations,he mortality from conscious sedation remains higher
han general anesthesia.3 Our Vascular Access Center
urrently has the capability to provide conscious seda-
ion. However, the success of tumescent local anesthesia
bviates the need for additional analgesia in our difficult
ases. Beyond allergic reaction, the major risk of lido-
aine injection is toxicity. The incidence of local anes-
hesia toxicity is 0.02% to 0.8% and is directly related to
he volume and concentration delivered.9,10 Tumescent
nesthesia has been widely used in much larger doses
han our study in an unmonitored office setting without
vidence of lidocaine toxicity.10 Our technique of tu-
escent infiltration required only 5 mg of lidocaine (5
L of 1% lidocaine). Furthermore, with the small vol-
me of tumescent anesthesia required to treat these focal
VF stenoses, pump-assisted injection is not necessary.
lthough our experience is limited, we feel the technique
s safe. The use of ultrasound guidance not only delivers
nesthesia at the site of the stenosis but also reduces the
isk of inadvertent intravenous injection.
The scope of our Access Center has grown beyond
ndovascular therapy of AVF and now includes hemodial-
sis catheter, port, and vena cava filter insertion and re-
oval. We believe tumescent local anesthesia provides a
etter safety profile that minimizes the risk of lidocaine
oxicity and avoids the risk of oversedation seen with mod-
rate conscious sedation.
Due to the small numbers of patients in this report, a
omparative study of patients without tumescent anesthesia
ould not be possible. Based on the success of our early
xperience with tumescent anesthesia, we believe a larger
ontrolled prospective investigation is indicated to deter-
ine the value of this novel technique of pain control in
ndovascular therapy. It is hoped the adoption of this
echnique may impact the risk associated with oversedation
uring endovascular procedures in higher risk patients.
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